Clinical Trial Update: Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the ability of mupirocin nasal ointment (Bactroban) to eradicate nasal carriage of Staphylococcus aureus; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• Bactroban nasal ointment (mupirocin)

Snippet

Sponsor: Destiny Pharma Plc | Conditions: Staphylococcal Infection | Phase 4 | Status: COMPLETED | Results posted: 2016-03-01